Collegeville-based Wyeth Pharmaceuticals announced today that the European Commission has granted marketing authorization for Conbriza, which treats postmenopausal osteoporosis.
Copyright PHILY - Philly.com
Collegeville-based Wyeth Pharmaceuticals announced today that the European Commission has granted marketing authorization for Conbriza, which treats postmenopausal osteoporosis.